NP Generic Medicines Transition Tender (October 2023)

A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")

Source
Find a Tender
Type
Framework (Supply)
Duration
27.5 month (est.)
Value
£845K
Sector
HEALTH
Published
26 Sep 2023
Delivery
To 13 Jan 2026 (est.)
Deadline
n/a

Concepts

Location

Edinburgh

Geochart for 2 buyers and 8 suppliers

2 buyers

7 suppliers

Description

This Procurement is for the supply of a range of Generic Medicines to health boards across NHS Scotland. The Goods have been split into four (4) individual Framework Agreements. Full details of each individual Framework Agreement is contained in section II.2 of this notice.

Lot Division

1 NP35923a Apixaban

Supply of Apixaban tablets in a range of presentations. The Authority will be awarding each product line as a multi-supplier unranked framework agreement to five (5) suppliers awarded to each line.
2 NP39723a Bexarotene

Supply of Bexarotene 75mg capsules to NHS Scotland. The Authority will be awarding the product line to a single Framework Participant within the single supplier Framework Agreement.
3 NP40923a Sugammadex

Supply of Sugammadex solution for injection vials, in a range of presentations to NHS Scotland. The Authority will be awarding each line to a single Framework Participant within the single supplier Framework Agreement.
4 NP36123a Atovaquone

Supply of Atovaquone 750mg/5ml oral suspension sugar free to NHS Scotland. The Authority will be awarding the product line to a single Framework Participant within the single supplier Framework Agreement.

Award Detail

1 Glenmark Pharmaceuticals Europe (Watford)
  • NP35923a Apixaban
  • Num offers: 5
  • Value: £161,316 [share]
  • Awarded to group of suppliers.
2 Selective Supplies (Haywards Heath)
  • NP35923a Apixaban
  • Num offers: 5
  • Value: £161,316 [share]
  • Awarded to group of suppliers.
3 Teva (Castleford)
  • NP35923a Apixaban
  • Num offers: 5
  • Value: £161,316 [share]
  • Awarded to group of suppliers.
4 Thornton & Ross (Huddersfield)
  • NP35923a Apixaban
  • Num offers: 5
  • Value: £161,316 [share]
  • Awarded to group of suppliers.
5 Viatris UK Healthcare (Hatfield)
  • NP35923a Apixaban
  • Num offers: 5
  • Value: £161,316 [share]
  • Awarded to group of suppliers.
6 Celix Pharma (London)
  • NP39723a Bexarotene
  • Num offers: 2
  • Value: £35,022
7 Glenmark Pharmaceuticals Europe (Watford)
  • NP36123a Atovaquone
  • Num offers: 1
  • Value: £96,219
8 DR Reddys Laboratories (Cambridge)
  • NP40923a Sugammadex
  • Num offers: 6
  • Value: £552,685

Award Criteria

API Sources 5.0
PRICE 95.0

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Award on basis of price.

Other Information

The estimated values referred to in Section II.1.5 and each Lot section of this Notice cover the forecasted spend for the duration of each individual Framework Agreement. For details of individual lines awarded within a Framework Agreement/Lot contact the named person at head of notice. (SC Ref:745745)

Reference

Domains